Literature DB >> 15809378

Differential aspects of endothelial function of the coronary microcirculation considering myocardial virus persistence, endothelial activation, and myocardial leukocyte infiltrates.

Katja B Vallbracht1, Peter L Schwimmbeck, Uwe Kühl, Ursula Rauch, Bettina Seeberg, Heinz-Peter Schultheiss.   

Abstract

BACKGROUND: Viral cardiomyopathy resulting from myocardial virus persistence can be associated with inflammatory immune responses that involve the myocardium and coronary blood vessels. The aim of this study was to investigate the differential impact of myocardial virus persistence and inflammation on endothelial function of the coronary microcirculation. METHODS AND
RESULTS: In 71 patients with nonischemic cardiomyopathy, myocardial biopsies were examined for virus persistence (by polymerase chain reaction) and inflammation (by immunohistology). Endothelial function of the coronary microcirculation was examined during heart catheterization by measuring diameter (by quantitative coronary angiography) and velocity changes (by intracoronary Doppler) of the left anterior descending artery in response to acetylcholine. Coronary blood flow (CBF) was calculated. Endothelium-independent vasoreactivity to adenosine was assessed. Mean age of the patients (37 men, 34 women) was 43+/-13 years; mean ejection fraction was 64+/-11%. In 43 patients, adenovirus, enterovirus, parvovirus, or HHV-6 was detected; 28 had no virus. Endothelial function of the coronary microcirculation was significantly impaired in patients with myocardial virus persistence (V) compared with patients without virus (Co) (DeltaCBF-V, 22+/-86%; DeltaCBF-Co, 110+/-113%; P=0.001), which was confirmed in 51 patients with myocardial inflammation (MC) (32 with virus, 19 with no virus) (DeltaCBF-MC-V, 12+/-89%; DeltaCBF-MC-Co, 81+/-109%; P=0.034) and in 20 patients with normal immunohistology of the myocardial biopsies (Co) (11 with virus, 9 with no virus) (DeltaCBF-Co-V, 51+/-72%; DeltaCBF-Co-Co, 175+/-97%; P=0.006). Endothelial function of the coronary microcirculation was also significantly impaired in patients with myocardial inflammation/endothelial activation compared with patients without inflammatory immune response. Endothelium-independent vasodilation was not influenced significantly.
CONCLUSIONS: Myocardial virus persistence and myocardial inflammation/endothelial activation are associated with endothelial dysfunction of the coronary microcirculation. Endothelial dysfunction in patients with myocardial virus persistence can occur independently of myocardial inflammation/endothelial activation but is more pronounced in patients with concurrent inflammation.

Entities:  

Mesh:

Year:  2005        PMID: 15809378     DOI: 10.1161/01.CIR.0000160863.30496.9B

Source DB:  PubMed          Journal:  Circulation        ISSN: 0009-7322            Impact factor:   29.690


  10 in total

1.  miRNA as activity markers in Parvo B19 associated heart disease.

Authors:  U Kühl; M Rohde; D Lassner; U M Gross; F Escher; H-P Schultheiss
Journal:  Herz       Date:  2012-09       Impact factor: 1.443

Review 2.  Meta-analysis on the immunohistological detection of inflammatory cardiomyopathy in endomyocardial biopsies.

Authors:  Julius L Katzmann; Peter Schlattmann; Angelos G Rigopoulos; Ewa Noutsias; Boris Bigalke; Matthias Pauschinger; Carsten Tschope; Daniel Sedding; P Christian Schulze; Michel Noutsias
Journal:  Heart Fail Rev       Date:  2020-03       Impact factor: 4.214

3.  Correlation of epicardial and systemic flow-mediated vasodilation in patients with atypical angina but no evidence of atherosclerotic disease.

Authors:  Katja B Vallbracht-Israng; Andreas Morguet; Peter L Schwimmbeck
Journal:  Can J Cardiol       Date:  2007-11       Impact factor: 5.223

4.  Acute phase proteins activation in subjects with coronary atherosclerosis and micro-vessel coronary circulation impairment.

Authors:  Natale Daniele Brunetti; Roberto Padalino; Luisa De Gennaro; Andrea Cuculo; Luigi Ziccardi; Pier Luigi Pellegrino; Matteo Di Biase
Journal:  J Thromb Thrombolysis       Date:  2008-08-09       Impact factor: 2.300

Review 5.  Viral myocarditis: diagnosis, aetiology and management.

Authors:  Uwe Kühl; Heinz-Peter Schultheiss
Journal:  Drugs       Date:  2009-07-09       Impact factor: 9.546

Review 6.  Infectious myocarditis: the role of the cardiac vasculature.

Authors:  Linde Woudstra; Lynda J M Juffermans; Albert C van Rossum; Hans W M Niessen; Paul A J Krijnen
Journal:  Heart Fail Rev       Date:  2018-07       Impact factor: 4.214

Review 7.  The Roles of Cardiac Fibroblasts and Endothelial Cells in Myocarditis.

Authors:  Yunling Xuan; Chen Chen; Zheng Wen; Dao Wen Wang
Journal:  Front Cardiovasc Med       Date:  2022-04-07

8.  The presence of cardiotropic viral genomes is not increased in atrial tissue of atrial fibrillation patients.

Authors:  L Wu; R W Emmens; J van Wezenbeek; W Stooker; C P Allaart; A B A Vonk; A C van Rossum; K C Wolthers; H W M Niessen; P A J Krijnen
Journal:  Neth Heart J       Date:  2022-01-31       Impact factor: 2.854

9.  Association of cytokines with endothelium dependent flow mediated vasodilation (FMD) of systemic arteries in patients with non-ischemic cardiomyopathy.

Authors:  Katja B Vallbracht-Israng; Ilkay Kazak; Peter L Schwimmbeck
Journal:  Cardiovasc Ultrasound       Date:  2007-12-10       Impact factor: 2.062

Review 10.  Cardiovascular consequences of viral infections: from COVID to other viral diseases.

Authors:  Heinz-Peter Schultheiss; Christian Baumeier; Heiko Pietsch; C-Thomas Bock; Wolfgang Poller; Felicitas Escher
Journal:  Cardiovasc Res       Date:  2021-11-22       Impact factor: 10.787

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.